Nationwide Fund Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-161,958
| Closed | -$13.3M | – | 2412 |
|
|
2017
Q3 | $13.3M | Buy |
161,958
+44,530
| +38% | +$3.67M | 0.05% | 485 |
|
|
2017
Q2 | $11M | Buy |
117,428
+74,558
| +174% | +$6.98M | 0.04% | 596 |
|
|
2017
Q1 | $2.73M | Buy |
42,870
+4,485
| +12% | +$286K | 0.01% | 1270 |
|
|
2016
Q4 | $1.71M | Buy |
38,385
+17,762
| +86% | +$789K | 0.01% | 1484 |
|
|
2016
Q3 | $743K | Hold |
20,623
| – | – | ﹤0.01% | 1961 |
|
|
2016
Q2 | $283K | Buy |
20,623
+2,754
| +15% | +$37.8K | ﹤0.01% | 2441 |
|
|
2016
Q1 | $343K | Sell |
17,869
-524
| -3% | -$10.1K | ﹤0.01% | 2286 |
|
|
2015
Q4 | $644K | Sell |
18,393
-81,796
| -82% | -$2.86M | ﹤0.01% | 1974 |
|
|
2015
Q3 | $9.21M | Buy |
100,189
+84,063
| +521% | +$7.73M | 0.04% | 566 |
|
|
2015
Q2 | $1.42M | Sell |
16,126
-18,100
| -53% | -$1.59M | 0.01% | 1654 |
|
|
2015
Q1 | $2.54M | Buy |
34,226
+13,483
| +65% | +$1M | 0.01% | 1327 |
|
|
2014
Q4 | $1.16M | Sell |
20,743
-255
| -1% | -$14.3K | 0.01% | 1727 |
|
|
2014
Q3 | $952K | Buy |
20,998
+25
| +0.1% | +$1.13K | ﹤0.01% | 1852 |
|
|
2014
Q2 | $868K | Buy |
20,973
+5,636
| +37% | +$233K | ﹤0.01% | 1948 |
|
|
2014
Q1 | $1.06M | Buy |
15,337
+1,479
| +11% | +$102K | ﹤0.01% | 1705 |
|
|
2013
Q4 | $835K | Buy |
13,858
+1,154
| +9% | +$69.5K | ﹤0.01% | 1972 |
|
|
2013
Q3 | $772K | Buy |
12,704
+2,264
| +22% | +$138K | ﹤0.01% | 1982 |
|
|
2013
Q2 | $699K | Buy |
+10,440
| New | +$699K | ﹤0.01% | 1853 |
|